Indomethacin for Alzheimer's disease

Naji Tabet1, Howard Feldman2
1Old Age Psychiatry, Maudsley Hospital, Department of Old Age Psychiatry, Maudsley Hospital, Denmark Hill, London, UK, SE5 8AZ.
2Vancouver Hospital and Health Sciences Center; UBC Division of Neurology; S192-2211 Wesbrook Mall Vancouver British Columbia Canada V6T 2B5

Tóm tắt

Từ khóa


Tài liệu tham khảo

Rogers, 1993, Clinical trial of indomethacin in Alzheimer's disease, Neurology, 43, 1609, 10.1212/WNL.43.8.1609

APA, 1994, American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

Beard, 1998, Nonsteroidal anti-inflammatory drug use and Alzheimer's disease: a case-control study in Rochester, Minnesota, 1980 through 1984, Mayo Clinic Proceedings, 73, 951, 10.4065/73.10.951

Bour, 2000, Interaction of indomethacin with cytokine production in whole blood. Potential mechanism for a brain-protective effect, Experimental Gerontology, 35, 1017, 10.1016/S0531-5565(00)00128-5

Clancy, 2000, Nitric oxide synthase/cox cross-talk: nitric oxide activates COX-1 but inhibits COX-2 derived prostaglandin production, Journal of Immunology, 165, 1582, 10.4049/jimmunol.165.3.1582

Dayton, 1996, Recombinant human interleukin 1b induces production of prostaglandins in primary human fetal astrocytes and immortalized human fetal astrocyte cultures, Journal of Neuroimmunology, 71, 11, 10.1016/S0165-5728(96)00111-7

Dollery, 1991, Indomethacin, Therapeutic Drugs, 1, 135

Du, 1999, Inhibitory effect of indomethacin in interleukin-1 and nitric oxide production in rat microglia in vitro, International Journal of Immunopharmacology, 21, 219, 10.1016/S0192-0561(98)00084-8

Eikelenboom, 1996, The role of complement and activated microglia in the pathogenesis of Alzheimer's disease, Neurobiology of Aging, 17, 673, 10.1016/0197-4580(96)00108-X

Fiebich, 1997, Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells, Journal of Neurochemistry, 68, 704, 10.1046/j.1471-4159.1997.68020704.x

Floyd, 1999, Neuroimmunology processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development, Free Radical Biology and Medicine, 26, 1346, 10.1016/S0891-5849(98)00293-7

Folstein, 1975, 'Mini-mental State': A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 12, 189, 10.1016/0022-3956(75)90026-6

Hellberg, 1981, Clinical pharmacokinetics of indomethacin, Clinical Pharmacokinetics, 6, 245, 10.2165/00003088-198106040-00001

Hodges, 1994, Cognitive assessment for clinicians

Hull, 2000, Anti-inflammatory drugs: a hope for Alzheimer's disease?, Expert Opinion on Investigational Drugs, 9, 671, 10.1517/13543784.9.4.671

ICD10, 1992, ICD-10 Classification of Mental and Behavioural Disorders: Clinical Description and Diagnostics Guidelines., none

int' Veld, 2001, Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease, New England Journal of Medicine, 345, 1515, 10.1056/NEJMoa010178

Kalaria, 1996, Molecular aspects of inflammatory and immune responses in Alzheimer's disease, Neurobiology of Aging, 17, 687, 10.1016/0197-4580(96)00114-5

McGeer, 1996, Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiological studies, Neurology, 47, 425, 10.1212/WNL.47.2.425

McKhann, 1984, Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 4, 933

Netland, 1998, Indomethacin reverses the microglial response to amyloid beta-protein, Neurobiology of Aging, 19, 201, 10.1016/S0197-4580(98)00047-5

O'Banion, 1996, Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer's disease, Neurobiology of Aging, 17, 669, 10.1016/0197-4580(96)00102-9

Rosen, 1984, A new rating scale for Alzheimer's disease, Am J Psychiatry, 141, 1356, 10.1176/ajp.141.11.1356

Stewart, 1997, Risk of Alzheimer's disease and duration of NSAID use, Neurology, 48, 626, 10.1212/WNL.48.3.626

Tabet, 2000, Free radicals as mediators of toxicity in Alzheimer's disease: a review and hypothesis, Adverse Drug Reactions and Toxicological Reviews, 19, 127

World Health Organisation, 1992, International Classification of Disease (ICD-10)

Tabet, Indomethacin for Alzheimer's disease, Cochrane Database of Systematic Reviews, 10.1002/14651858.CD003673